Community/Retail

Confusion over the drug strength displayed for the new antibacterial agent Avycaz could cause medication errors, the FDA is warning pharmacists.

Up to 60% of patients with gastroesophageal reflux disease (GERD) continue to have symptoms despite proton-pump inhibitor (PPI) therapy.

While college students acknowledge the importance of being financially responsible, many don't actually have good financial habits.

Old drugs with new price hikes add another dimension to the national drug pricing debate.

Citing a rare yet serious risk of slowed breathing, the FDA is evaluating the use of the opioid pain medication tramadol (Ultram, Ultram ER, Conzip) in the pediatric population.

Abbott's commitment to support working mothers with progressive benefits and extraordinary career opportunities was recognized today by Working Mother magazine.

National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement regarding today's hearing of the Senate Judiciary Committee Subcommittee on Antitrust, Competition Policy and Consumer Rights.

Take this short quiz to find out your chances of getting into pharmacy school.

Pregabalin and gabapentin are often considered first-line treatments for various neuropathic pain syndromes, generally irrespective of cause.

The International Pharmaceutical Federation (FIP) has updated the practice standards used by hospital pharmacists worldwide.

The more orders pharmacists have to verify, the more likely they are to make mistakes.

Draft guidelines from the US Centers for Disease Control and Prevention (CDC) could sharply reduce the role opioids play in primary care-based pain management.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses how MinuteClinic enhances COPD management.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about how to prepare community pharmacists to provide both behavioral and pharmacotherapeutic smoking cessation advice.

A pharmacy and health sciences university in Boston beats prestigious schools like Harvard and the Massachusetts Institute of Technology (MIT) on average salary among alumni.

Greater pharmacist involvement in care transitions could curb the many medication discrepancies that arise throughout the process.

A new study provides evidence that patients' patterns of medication fills in the first few months after starting on a chronic therapy accurately predict future medication adherence behavior.

Although respiratory sleep disorders occur in up to half of all congestive heart failure (CHF) cases, they remain underdiagnosed in CHF.

The demands that pharmacists are expected to meet can make burnout commonplace.

Pharmacists are trained to rise above the fear of imperfection.

Henry Dale Smith Sr., the founder and chairman emeritus of H. D. Smith, has passed away at age 87.

Allergan has announced a nationwide partnership with the Caregiver Action Network to provide thank you meals to 1,000 family caregivers across the country through a new initiative called Take 1 Moment.

Boehringer Ingelheim and BioMed X have successfully applied a crowdsourcing approach to establish a research team of outstanding scientists who will endeavor to identify new approaches for the treatment of patients with chronic obstructive pulmonary disease

A generic version of Novartis' lipid-lowering Lescol XL is now available in the United States.

Doug Long, vice president of industry relations at IMS Health, talks about trends pharmacists should look out for in the future.

Planned Parenthood funding cuts would save taxpayers $235 million over a decade, but also reduce health care access for nearly 400,000 women and children.

The FDA is changing dispensing requirements for the schizophrenia drug clozapine (Clozaril) to address safety concerns about severe neutropenia.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses metrics in care transitions that pharmacists should pay attention to.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, discusses how community pharmacies can build new networks of customers.

Doug Long, vice president of industry relations at IMS Health, talks about how the movement toward value-based care in the US health system affects community pharmacy.